Mobile

Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-005573-36

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To demonstrate the non-inferiority of DC120 on hair growth, versus a reference product (ALOSTIL®), in the treatment of androgenetic alopecia, over 16 weeks.

Critère d'inclusion

  • androgenetic alopecia

Liens